Couple of things i took from the webinar, firstly the trial is progressing better than expected so timeframes should be exceeded which is a big positive imo. Secondly when asked how conversations with pharma were going Liz didnt seem as positive and seemed (maybe to cynical me anyway) to throw cold water on the question when asked , and indicated that may be a while down the track until P2 data has been received ?
Ann: Phase 2 Stroke Clinical Trial Update, page-24
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
74.5¢ |
Change
0.010(1.36%) |
Mkt cap ! $95.42M | |||
| Open | High | Low | Value | Volume |
| 75.8¢ | 77.5¢ | 74.5¢ | $61.58K | 81.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 74.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 77.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| AGN (ASX) Chart |